Skip to main content

Peer Review reports

From: Efficacy of second-line treatment and prognostic factors in patients with advanced malignant peritoneal mesothelioma: a retrospective study

Original Submission
1 Jan 2021 Submitted Original manuscript
10 Jan 2021 Reviewed Reviewer Report - Nobukazu Fujimoto
13 Jan 2021 Reviewed Reviewer Report - Takahiro Mimae
24 Jan 2021 Reviewed Reviewer Report - Masaki Hashimoto
27 Jan 2021 Author responded Author comments - Tatsunori Shimoi
Resubmission - Version 2
27 Jan 2021 Submitted Manuscript version 2
28 Jan 2021 Author responded Author comments - Tatsunori Shimoi
Resubmission - Version 3
28 Jan 2021 Submitted Manuscript version 3
24 Feb 2021 Author responded Author comments - Tatsunori Shimoi
Resubmission - Version 4
24 Feb 2021 Submitted Manuscript version 4
26 Feb 2021 Author responded Author comments - Tatsunori Shimoi
Resubmission - Version 5
26 Feb 2021 Submitted Manuscript version 5
28 Feb 2021 Author responded Author comments - Tatsunori Shimoi
Resubmission - Version 6
28 Feb 2021 Submitted Manuscript version 6
1 Mar 2021 Author responded Author comments - Tatsunori Shimoi
Resubmission - Version 7
1 Mar 2021 Submitted Manuscript version 7
1 Mar 2021 Author responded Author comments - Tatsunori Shimoi
Resubmission - Version 8
1 Mar 2021 Submitted Manuscript version 8
5 Mar 2021 Reviewed Reviewer Report - Nobukazu Fujimoto
6 Mar 2021 Reviewed Reviewer Report - Takahiro Mimae
Resubmission - Version 9
Submitted Manuscript version 9
Publishing
8 Mar 2021 Editorially accepted
20 Mar 2021 Article published 10.1186/s12885-021-08025-x

You can find further information about peer review here.

Back to article page